Agilent to acquire Proscia for $240M in cash
- Agilent Technologies (A) on Tuesday said it has entered into a definitive agreement to acquire Proscia in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones.
- Proscia is an independent provider of enterprise digital pathology software.
- Proscia serves more than 4,000 laboratories, hospitals, and clinics, with trailing twelve months revenue exceeding $18 million, the company said.
- Agilent and Proscia entered into a multi-year distribution agreement in September 2022 to offer a comprehensive digital diagnostic-pathology system.
- Press release
Recommended For You
Register for free to keep reading.
Create a free account to get unlimited breaking news and alerts when your stocks move.
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.